Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT03043924

NCT03043924
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are between 19 and 30 years old
  • Your body mass index (a measure of body weight relative to height) is between 18 and 25
  • You are willing and able to give your written agreement to take part before the study begins
  • You have not smoked in the 3 days before your MRI scan

If you are a healthy volunteer, you also need to meet these conditions:

  • Your menstrual cycles are regular (between 25 and 35 days) and you ovulate normally
  • You have no signs of excess male hormones (such as excess hair growth or acne) (confirm with trial site)
  • You are willing to start taking a combined oral contraceptive pill (containing both oestrogen and progestin)
  • For your second MRI scan: you will need to have been taking a specific low-dose combined contraceptive pill correctly for 3 months (confirm with trial site for exact pill details)

If you have Polycystic Ovary Syndrome (PCOS), you also need to meet these conditions:

  • You have been diagnosed with PCOS using a standard set of medical criteria called the Rotterdam criteria (confirm with trial site)
  • You need treatment with a medication called cyproterone acetate
  • For your second MRI scan: you will need to have been taking cyproterone acetate combined with a specific form of oestrogen correctly for 3 months (confirm with trial site for exact medication details)

Who may not be able to join:

  • You have taken any hormone treatment, including the contraceptive pill, in the last 3 months
  • You are currently pregnant (this will be checked before each MRI scan)
  • You experience claustrophobia (fear of enclosed spaces, such as an MRI scanner)
  • You have any metal objects or implants inside your body, such as aneurysm clips, ear implants, a pacemaker, or a defibrillator
  • You have diabetes or a known thyroid condition
  • You currently misuse substances, including smoking more than 5 cigarettes per day (this will be checked at your first visit)
  • You have been pregnant or breastfeeding in the last 3 months
  • You did intense exercise (for example, running more than 10 km) the day before your MRI scan
  • You are not able to give your own informed consent, or you are under a form of legal guardianship
  • You are unable to understand the treatment plan for this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
University Hospital, Lille
Registry
clinicaltrials_gov
Start date
26 September 2017
Est. completion
15 April 2022

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in the Apparent Diffusion Coefficient (ADC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov